Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SELEXIPAG vs SEMAGLUTIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SELEXIPAG vs SEMAGLUTIDE: Safety Overview

Metric SELEXIPAG SEMAGLUTIDE
Total FAERS Reports 18,471 59,604
Deaths Reported 3,778 792
Death Rate 20.5% 1.3%
Hospitalizations 9,394 11,258
Average Patient Age 58.4 yrs 59.1 yrs
% Female Patients 71.9% 66.6%
FDA Approval Date Dec 21, 2015 Apr 9, 2019
Manufacturer Zydus Pharmaceuticals (USA) Inc. Novo Nordisk
Route ORAL ORAL
Marketing Status Prescription Discontinued